← Leaderboards
Elisa V Bandera
Rutgers Biomedical And Health Sciences
$5,946,911
Attributed
$15,782,001
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,782,001 · 7
By mechanism
R01$13,245,454 · 2
P01$836,337 · 1
K07$671,826 · 1
K22$605,481 · 1
P30$422,903 · 2
Top collaborators
- Kitaw Demissie11 shared
- Chi-Chen Hong11 shared
- Jennifer A. Doherty9 shared
- Scarlett L Gomez9 shared
- Lawrence H Kushi9 shared
- Robert C Millikan1 shared
Most similar at Rutgers Biomedical And Health Sciences
Same institution · by research overlap
- Steven K. Libutti$7,794,095
Others in their field
Top investigators on “Characteristics”
- Lawrence Corey · Fred Hutchinson Cancer Center$259,409,773
- Jeffrey P Krischer · University Of South Florida$234,914,225
- Constance Ann Benson · University Of California, San Diego$187,977,954
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$136,053,061
- Peter B. Gilbert · Fred Hutchinson Cancer Center$118,817,242
Research focus
CharacteristicsTumorCohortWomanDiagnosisAfrican AmericanDosePrognosticRaceBody Mass IndexChemotherapyUnited StatesClinical ManagementGuidelinesMalignant Breast NeoplasmComorbidityMortalityCaringBiologicalTreatment OutcomeRisk FactorsStressSurvivorshipMalignant Neoplasms
Grant awards (34)
Identifying Multilevel Drivers of Differences in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,067,936
R01 · FY2025 · CA
Cancer Prevention and Control$269,566
P30 · FY2025 · CA · contact PI
Cancer Prevention and Control$114,250
P30 · FY2025 · CA · contact PI
Cancer Prevention and Control$9,429
P30 · FY2024 · CA · contact PI
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1
R01 · FY2024 · CA
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,365,470
R01 · FY2023 · CA
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$100,833
R01 · FY2023 · CA
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,445,236
R01 · FY2022 · CA
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$199,995
R01 · FY2022 · CA
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$102,222
R01 · FY2022 · CA
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,386,624
R01 · FY2021 · CA
Cancer Prevention and Control$29,658
P30 · FY2021 · CA · contact PI
Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival: An Integrative Approach$1,371,104
R01 · FY2020 · CA
Obesity, related comorbidities, and breast cancer outcomes in African Americans$1,038,141
R01 · FY2018 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$68,187
R01 · FY2018 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$1,327,573
R01 · FY2017 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$68,187
R01 · FY2017 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$1,317,553
R01 · FY2016 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$94,198
R01 · FY2016 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$68,187
R01 · FY2016 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$1,138,361
R01 · FY2015 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$141,499
R01 · FY2015 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$47,301
R01 · FY2015 · CA · contact PI
Obesity, related comorbidities, and breast cancer outcomes in African Americans$896,846
R01 · FY2014 · CA · contact PI
Obesity in ovarian cancer prognosis$104,660
K22 · FY2012 · CA · contact PI
Obesity in ovarian cancer prognosis$96,721
K22 · FY2012 · CA · contact PI
Data Collection$836,337
P01 · FY2011 · CA · contact PI
Obesity in ovarian cancer prognosis$201,060
K22 · FY2011 · CA · contact PI
Obesity in ovarian cancer prognosis$203,040
K22 · FY2010 · CA · contact PI
Phytoestrogens, alcohol, and endometrial cancer risk$134,460
K07 · FY2007 · CA · contact PI
Phytoestrogens, alcohol, and endometrial cancer risk$134,460
K07 · FY2006 · CA · contact PI
Phytoestrogens, alcohol, and endometrial cancer risk$134,460
K07 · FY2005 · CA
Phytoestrogens, alcohol, and endometrial cancer risk$134,226
K07 · FY2004 · CA
Phytoestrogens, alcohol, and endometrial cancer risk$134,220
K07 · FY2003 · CA